Institutions team up to form 'collective...
Glioblastoma multiforme, the most common and lethal form of brain cancer, "is one of the science and medical world's hardest nuts to crack," writes W.K. Alfred Yung, M.D., chair of Neuro-Oncology at MD Anderson, in a guest blog at Cure.
Yung explains how an alliance formed this year called Defeat GBM Research Collaborative reaches across institutions to improve collaboration and data sharing through an innovative scientific plan...
FDA lymphoma drug approval based on MD Anderson-led clinical trial
The U.S. Food and Drug Administration today approved ibrutinib for treatment of patients with mantle cell lymphoma who have received...
Advanced form of proton therapy offers benefits for head, neck...
Oral cancer patients with tumors at the back of the throat are half as likely to require a feeding tube when treated with intensity...